Description
Glimepiride IP 2mg + Voglibose IP 0.2mg +Metformin Hydrochloride IP 500 mg (As Sustained Release )
Voglibose
Voglibose scored over both acarbose and intestine level and thereby prevent sudden surge of glucose after a meal
Glimepride
Effective , safe and well tolerated as a short term intensive treatment in newly diagnosed type 2 diabetic patients
diagnosed type 2 diabetic patients
A combination of glimepiride with metformin achieves good glycemic control with better tolerability profile .
Metformin
Is a first -line antihyperglycemic agent commonly prescribed in type 2 diabetes mellitus (T2DM)
Improves carbohydrate and lipid metabolism and shows a pronounced cardio and neuroprotective effects.
